Showing 2261-2270 of 2652 results for "".
- Large Employers are Eyeing On-Site COVID-19 Vaccines, Survey Showshttps://modernod.com/news/large-employers-are-eyeing-on-site-covid-19-vaccines-survey-shows/2479044/Many large employers are expecting to offer COVID-19 vaccines on-site for workers by the end of the year, a new survey shows, according to a Fierce Healthcare
- Pfizer, BioNTech Initiate Study of COVID-19 Vaccine in Children Under 12https://modernod.com/news/pfizer-biontech-initiate-study-of-covid-19-vaccine-in-children-under-12/2479017/Pfizer and BioNTech said Thursday that they have started testing their COVID-19 vaccine BNT162b2 in children ages 6 months to 11 years old, with initial results expected in the second half of the year. The mRNA-based vaccine is currently authorized for people 16 years and older in multiple market
- Aura Biosciences Names Mark De Rosch, PhD, Chief Operating Officerhttps://modernod.com/news/aura-biosciences-names-mark-de-rosch-phd-chief-operating-officer/2479008/Aura Biosciences announced the appointment of Mark De Rosch, PhD, as Chief Operating Officer. In his role, he will be responsible for leading Aura’s global operations and regulatory strategy. Dr. De Rosch brings to Aura more than 30 years of experience in leading global regulatory and deve
- Judy F. Gordon, DVM, Founder of ClinReg Consulting Services, Retireshttps://modernod.com/news/judy-f-gordon-dvm-founder-of-clinreg-consulting-services-retires/2479004/Medical device and pharmaceutical consulting company ClinReg Consulting Services announced the retirement of its founder and president, Judy F. Gordon, DVM. Dr. Gordon has worked in the clinical and regulatory industry for more than 35 years, beginning with her career in the pharmaceutical
- Santen EMEA Appoints Dr. Ioana Grobeiu as Vice President, Medical Affairshttps://modernod.com/news/santen-emea-appoints-dr-ioana-grobeiu-as-vice-president-medical-affairs/2479000/Santen EMEA has announced the appointment of Dr. Ioana Grobeiu as Vice President, Medical Affairs. With over 20 years of experience in pharmaceuticals, Dr. Grobeiu will lead the medical affairs strategy and report to Luis Iglesias, President and Head of Santen EMEA. Dr. Grobeiu will delive
- SemaThera Enters into a Research Collaboration and Exclusive License Agreement with Rochehttps://modernod.com/news/semathera-enters-into-a-research-collaboration-and-exclusive-license-agreement-with-roche/2478997/SemaThera announced the signing of a multi-year research collaboration and licensing agreement with Roche to advance SemaThera’s new class of biologicals for the treatment of diabetic retinopathy and other ischemic retinal diseases. Terms of the deal were not disclosed. “We are very
- HK Scientist Develops Retinal Scan Technology to Identify Early Childhood Autismhttps://modernod.com/news/hk-scientist-develops-retinal-scan-technology-to-identify-early-childhood-autism/2478987/A Hong Kong scientist has developed a method to use machine learning and artificial intelligence to scan retinas of children as young as six to detect early autism or the risk of autism and hopes to develop a commercial product this year, according to a Reuters
- Rabb-Venable Excellence in Ophthalmology Program Abstract Submission Open Until March 31https://modernod.com/news/rabb-venable-excellence-in-ophthalmology-program-abstract-submission-open-until-march-31/2478981/Each year, the National Medical Association–Ophthalmology Section sponsors the Rabb-Venable Excellence in Ophthalmology Program, which is committed to increasing diversity in eye care to better reflect the U.S. population. The Rabb-Venable Program encourages and fosters interest in ophthal
- CORE Offers Tips on Seeking Eye Care During the Pandemic, Provides Free Infographics for ECPs to Use with Patientshttps://modernod.com/news/core-offers-tips-on-seeking-eye-care-during-the-pandemic-provides-free-infographics-for-ecps-to-use-with-patients/2478959/As the global COVID-19 pandemic enters its second year, a new initiative from the Centre for Ocular Research & Education (CORE) is addresses questions that may keep people from seeking proper eye care. CORE has designed
- Adverum Announces Shortened Timelines and Development Path for ADVM-022 Intravitreal Gene Therapy in Wet AMDhttps://modernod.com/news/adverum-announces-shortened-timelines-and-clear-development-path-for-advm-022-intravitreal-gene-therapy-in-wet-amd/2478955/Adverum Biotechnologies announced that it has gained alignment with the FDA on the clinical development path for ADVM-022, an investigational single, in-office intravitreal (IVT) injection gene therapy for the treatment of wet age-related macular degeneration (AMD